This blog post delves into the role of tau protein in both the healthy brain and in neurodegenerative diseases, including Alzheimer's and other tauopathies. By understanding tau's dual nature, we highlight its potential as a target for therapeutic interventions.
ReadThis blog post explores prion diseases, a unique class of neurodegenerative diseases caused by misfolded proteins. Understanding the properties and pathogenesis of prions can shed light on other disorders involving protein misfolding and aggregation.
ReadThis blog post offers a detailed look at alpha-synuclein, a protein implicated in Parkinson's disease. It explores the role of this protein in disease pathogenesis and the potential it holds as a target for future therapeutic interventions.
ReadThis blog post explores how the biological changes that come with ageing can increase the risk and affect the progression of neurodegenerative diseases. It underscores the importance of further research to understand these relationships and develop effective treatments.
ReadThis blog post delves into the molecular mechanisms of neurotoxicity, describing the various ways in which neurotoxic substances can damage the brain and potential strategies for protecting against such damage.
ReadThis blog post explores the role of protein aggregation in neurodegenerative diseases. By delving into the process of protein misfolding and its impact on neuronal health, we discuss the research efforts in understanding these molecular phenomena and potential therapeutic strategies.
ReadThis blog post explores the role of the complement system in neurodegeneration, highlighting its function in the immune system and its potential contribution to conditions like Alzheimer's and Parkinson's disease. The post also discusses possible therapeutic strategies targeting the complement system.
ReadThis blog post explores the intriguing relationship between autophagy, a vital cellular process, and neurodegenerative diseases. We discuss the role of autophagy in neuronal health, its link to various neurodegenerative diseases, and the potential for targeting autophagy in therapeutic strategies.
ReadIn this blog post, we discuss the potential role of cytoplasmic dynein 1, a motor protein involved in essential cellular processes, in the pathology of amyotrophic lateral sclerosis (ALS) and explore how targeting this protein or its associated pathways could represent a promising therapeutic strategy for the disease.
ReadIn this blog post, we discuss the importance of bioinformatics in amyotrophic lateral sclerosis (ALS) research and how this interdisciplinary field contributes to the identification of novel therapeutic targets, drug repurposing, and personalised medicine strategies.
ReadIn this blog post, we delve into the role of TAR DNA-binding protein 43 (TDP-43) in the pathology of amyotrophic lateral sclerosis (ALS), discussing its involvement in RNA metabolism and how targeting this protein or its associated pathways may offer promising therapeutic strategies for the disease.
ReadThis blog post explores the double-edged sword of neuroinflammation in neurodegenerative diseases. We discuss its role as both a protective mechanism and a potential contributor to disease progression, and the ongoing research to balance these effects for therapeutic benefit.
ReadThis blog post explores the intriguing link between mitochondrial dysfunction and neurodegenerative diseases. We delve into the roles of mitochondria in cells, examine the evidence connecting mitochondrial dysfunction to neurodegeneration, and consider the promising therapeutic strategies targeting mitochondria.
ReadIn this blog post, we delve into the impact of oxidative stress on neuronal health. We cover what oxidative stress is, how it affects neurons, its role in neurodegenerative diseases, and potential strategies for targeting oxidative stress in these conditions.
Read